HeraMED Limited announced that Mr. David Groberman has resigned as Managing Director with immediate effect. David will continue in a non-Executive role, as Product Strategist, delivering advice and strategic input on the evolution of the technology. Dr. Ron Weinberger will continue as Executive Chairman, leading the commercialisation of HeraCARE until a permanent Managing Director and CEO is found.

A search will commence at the appropriate time and further announcements will be made at the appropriate time. The role of CFO will be outsourced to Shimony Finance Partner Mr. Ido Toronchik.